SCHEMBL2729965

SCHEMBL2729965

Cc1cc(-c2ccc(-c3ccc(OCC4OC4C)cc3)cc2)ccc1OCC1OC1C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 5/20 0.39
PPARG P37231 4/20 0.39
PPARA Q07869 2/20 0.39
MRGPRX4 Q96LA9 1/20 0.35
FFAR4 Q5NUL3 2/20 0.35
ALDH1A1 P00352 2/20 0.33
SLC5A2 P31639 2/20 0.33
GLA P06280 1/20 0.33
PTGER4 P35408 1/20 0.33
TP53 P04637 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
TSHR P16473 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP1A2 P05177 1/20 0.32
HIF1A Q16665 1/20 0.32
SLC5A1 P13866 1/20 0.32
AAK1 Q2M2I8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2729397 0.87 FFAR4 (0.34) PPARDPPARGPPARAFFAR4ALDH1A1
SCHEMBL2729981 0.86 FFAR4 (0.33) PPARDPPARGPPARAFFAR4ALDH1A1
SCHEMBL2720240 0.85 PPARG (0.40) PPARDPPARGPPARAMRGPRX4FFAR4
SCHEMBL2829748 0.84 TP53 (0.37) PPARGFFAR4ALDH1A1TP53MAPT
SCHEMBL2731903 0.81 SLC5A2 (0.34) ALDH1A1SLC5A2GLASLC5A1
SCHEMBL2720790 0.81 ALDH1A1 (0.55) PPARDPPARGPPARAMRGPRX4FFAR4
SCHEMBL18935421 0.81 ALDH1A1 (0.55) PPARDPPARGPPARAMRGPRX4FFAR4
SCHEMBL2729773 0.80 SSTR4 (0.40) MRGPRX4ALDH1A1SLC5A2GLASLC5A1
SCHEMBL2729993 0.78 MCHR1 (0.32)
SCHEMBL2729949 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1995245-B1 METHOD FOR PRODUCING EPOXY COMPOUND SUMITOMO CHEMICAL CO (JP) 2012-05-02 EP disclosed
US-20100160555-A1 RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-24 US disclosed
US-20100144926-A1 EPOXY RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-10 US disclosed
EP-2133379-A1 EPOXY RESIN COMPOSITION Sumitomo Chemical Company, Limited (JP) 2009-12-16 EP disclosed
EP-2133380-A1 RESIN COMPOSITION Sumitomo Chemical Company, Limited (JP) 2009-12-16 EP disclosed
US-20090054669-A1 Process For Producing Epoxy Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-02-26 US disclosed
US-20090018355-A1 Process for Crystallizing an Epoxy Compound SUMITOMO CHEMICAL COMPANY, LTD. 2009-01-15 US disclosed
EP-1995245-A1 METHOD FOR PRODUCING EPOXY COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-11-26 EP disclosed
EP-1995244-A1 METHOD FOR CRYSTALLIZATION OF EPOXY COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018355-A1 Process for Crystallizing an Epoxy Compound PTGER1, NR5A1, TCP1 PPARD 4113/4885PPARG 2038/4885PPARA 3623/4885
US-20090054669-A1 Process For Producing Epoxy Compound RER1, AR, CYP1A1 PPARD 3581/4885PPARG 2278/4885PPARA 2813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.